Page 30 - ARNM-2-1
P. 30

Advances in Radiotherapy
            & Nuclear Medicine                                             Is 5-mm PTV margin 4D-CT-based radiotherapy



               respiratory motion in radiation oncology report of AAPM   2007;67(3):727-734.
               task group 76. Med Phys. 2006;33(10):3874-3900.
                                                                  doi: 10.1016/j.ijrobp.2006.08.057
               doi: 10.1118/1.2349696
                                                               20.  Mori  S, Kanematsu  N, Mizuno  H, Sunaoka  M, Endo  M.
            11.  Plathow C, Ley S, Fink C,  et al. Analysis of intrathoracic   Physical evaluation of CT scan methods for radiation
               tumor mobility during whole breathing cycle by dynamic   therapy planning: Comparison of fast, slow and gating scan
               MRI. Int J Radiat Oncol Biol Phys. 2004;59(4):952-959.  using the 256-detector row CT scanner.  Phys Med Biol.
                                                                  2006;51(3):587-600.
               doi: 10.1016/j.ijrobp.2003.12.035
                                                                  doi: 10.1088/0031-9155/51/3/008
            12.  Ahmed N, Venkataraman S, Johnson K, Sutherland K,
               Loewen SK. Does motion assessment with 4-dimensional   21.  Pierce G.  Assessing and Improving 4D-CT Imaging for
               computed tomographic imaging for non-small cell lung   Radiotherapy Applications Western Thesis and Dissertation
               cancer radiotherapy improve target volume coverage? Clin   Repository; 2011.
               Med Insights Oncol. 2017;11:1-7.
                                                               22.  Alasti H, Cho YB, Vandermeer AD,  et al. A novel four-
               doi: 10.1177/1179554917698461                      dimensional radiotherapy method for lung cancer:
                                                                  Imaging, treatment planning and delivery. Phys Med Biol.
            13.  De Ruysscher D, Faivre-Finn C, Nestle U, et al. European
               organisation for research and treatment of cancer   2006;51(12):3251-3267.
               recommendations for planning and delivery of high-dose,      doi: 10.1088/0031-9155/51/12/017
               high-precision radiotherapy for lung cancer. J Clin Oncol.   23.  Ju X, Li M, Zhou Z, et al. 4D-CT-based plan target volume
               2010;28(36):5301-5310.
                                                                  (PTV) definition compared with conventional PTV
               doi: 10.1200/JCO.2010.30.3271                      definition using general margin in radiotherapy for lung
                                                                  cancer. Zhonghua Zhong Liu Za Zhi. 2014;36(1):34-38.
            14.  Rietzel E, Chen GT, Choi NC, Willet CG. Four-
               dimensional image-based treatment planning: Target   24.  Cole AJ, O’Hare JM, McMahon SJ, et al. Investigating the
               volume segmentation and dose calculation in the presence   potential impact of four-dimensional computed tomography
               of respiratory motion.  Int J Radiat Oncol Biol Phys.   (4DCT)  on  toxicity,  outcomes  and  dose  escalation  for
               2005;61(5):1535-1550.                              radical lung cancer radiotherapy. Clin Oncol (R Coll Radiol).
                                                                  2014;26(3):142-150.
               doi: 10.1016/j.ijrobp.2004.11.037
                                                                  doi: 10.1016/j.clon.2013.11.024
            15.  Steiner E, Shieh CC, Caillet V, et al. Both four-dimensional
               computed tomography and four-dimensional cone beam   25.  Kong F, Hu C, Machtay M, et al. OA02.04 randomized phase
               computed tomography under-predict lung target motion   II trial (RTOG1106) on midtreatment PET/CT guided
               during radiotherapy. Radiother Oncol. 2019;135:65-73.  adaptive radiotherapy in locally advanced non-small cell
                                                                  lung cancer. J Thorac Oncol. 2021;16(3):S104-S105.
               doi: 10.1016/j.radonc.2019.02.019
                                                                  doi: 10.1016/j.jtho.2021.01.277
            16.  Glide-Hurst CK, Schwenker Smith M, Ajlouni M, Indrin J,
               Chetty IJ. Evaluation of two synchronized external surrogates   26.  Van Diessen J, De Ruysscher D, Sonke JJ, et al. The acute
               for 4D CT sorting. J Appl Clin Med Phys. 2013;14(6):4301.  and late toxicity results of a randomized phase II dose-
                                                                  escalation  trial  in  non-small  cell  lung  cancer  (PET-boost
               doi: 10.1120/jacmp.v14i6.4301
                                                                  trial). Radiother Oncol. 2019;131:166-173.
            17.  Kong FM, Ritter T, Quint DJ, et al. Consideration of dose
               limits  for  organs  at risk of  thoracic  radiotherapy:  Atlas      doi: 10.1016/j.radonc.2018.09.019
               for lung, proximal bronchial tree, esophagus, spinal cord,   27.  Van Herk M, Remeijer P, Rasch C, Lebesque JV. The
               ribs, and brachial plexus.  Int J Radiat Oncol Biol Phys.   probability  of  correct  target  dosage:  Dose-population
               2011;81(5):1442-1457.                              histograms for deriving treatment margins in radiotherapy.
                                                                  Int J Radiat Oncol Biol Phys. 2000;47(4):1121-1135.
               doi: 10.1016/j.ijrobp.2010.07.1977
                                                                  doi: 10.1016/s0360-3016(00)00518-6
            18.  Grills IS, Fitch DL, Goldstein NS, et al. Clinicopathologic
               analysis of microscopic extension in lung adenocarcinoma:   28.  Stroom JC, Heijmen BJ. Geometrical uncertainties,
               Defining clinical target volume for radiotherapy. Int J Radiat   radiotherapy planning margins, and the ICRU-62 report.
               Oncol Biol Phys. 2007;69(2):334-341.               Radiother Oncol. 2002;64(1):75-83.
               doi: 10.1016/j.ijrobp.2007.03.023                  doi: 10.1016/s0167-8140(02)00140-8
            19.  Yuan S, Meng X, Yu J, et al. Determining optimal clinical   29.  Ecclestone G,  Heath  E,  Bissonnette  JP. Poster-thur
               target volume margins on the basis of microscopic   Eve-62: Assessing the clinical application of the van
               extracapsular extension of metastatic nodes in patients with   Herk margin formula for lung radiotherapy.  Med  Phys.
               non-small-cell lung cancer.  Int J Radiat Oncol Biol  Phys.   2012;39(7Part3):4636.


            Volume 2 Issue 1 (2024)                         9                       https://doi.org/10.36922/arnm.2784
   25   26   27   28   29   30   31   32   33   34   35